These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 891024)

  • 1. C3 metabolism in ulcerative colitis and Crohn's disease.
    Hodgson HJ; Potter BJ; Jewell DP
    Clin Exp Immunol; 1977 Jun; 28(3):490-5. PubMed ID: 891024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proceedings: Complement in inflammatory bowel disease.
    Hodgson HJ; Potter BJ; Jewell DP
    Gut; 1975 Oct; 16(10):833-4. PubMed ID: 1205305
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.
    Sissons JG; Liebowitch J; Amos N; Peters DK
    J Clin Invest; 1977 Apr; 59(4):704-15. PubMed ID: 845257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal radioiodide excretion following intravenous injection of 131-I-albumin and 125-I-immunoglobulin G in chronic inflammatory bowel disease. An aid to topographic diagnosis.
    Jarnum S; Jensen KB
    Gastroenterology; 1975 Jun; 68(6):1433-44. PubMed ID: 1132626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immune system activity in inflammatory bowel disease.
    Teisberg P; Gjone E
    Scand J Gastroenterol; 1975; 10(5):545-9. PubMed ID: 1171519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis.
    Potter BJ; Elias E; Jones EA
    J Lab Clin Med; 1976 Sep; 88(3):427-39. PubMed ID: 956695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced local production of complement components in the small intestines of patients with Crohn's disease.
    Ahrenstedt O; Knutson L; Nilsson B; Nilsson-Ekdahl K; Odlind B; Hällgren R
    N Engl J Med; 1990 May; 322(19):1345-9. PubMed ID: 2325733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
    Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
    Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallikrein-kinin system activation in Crohn's disease: differences in intestinal and systemic markers.
    Devani M; Cugno M; Vecchi M; Ferrero S; Di Berardino F; Avesani EC; de Franchis R; Colman RW
    Am J Gastroenterol; 2002 Aug; 97(8):2026-32. PubMed ID: 12190172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum C3 and C4 complement components in ulcerative colitis and Crohn's disease.
    Ward M; Eastwood MA
    Digestion; 1975; 13(1-2):100-3. PubMed ID: 1201816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
    Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
    Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein patterns in serum and peritoneal fluid in Crohn's disease and ulcerative colitis.
    Haglund U; Hultén L
    Acta Chir Scand; 1976; 142(2):160-4. PubMed ID: 936940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease.
    Nielsen OH; Brynskov J; Bendtzen K
    Dan Med Bull; 1993 Apr; 40(2):247-9. PubMed ID: 8495600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of vitamin A in inflammatory bowel disease.
    Janczewska I; Bartnik W; Butruk E; Tomecki R; Kazik E; Ostrowski J
    Hepatogastroenterology; 1991 Oct; 38(5):391-5. PubMed ID: 1765354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold-reactive lymphocytotoxins in Crohn's disease and ulcerative colitis. I. Incidence and characterization.
    Brown DJ; Jewell DP
    Clin Exp Immunol; 1982 Jul; 49(1):67-74. PubMed ID: 6982133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history].
    Nos P; Argüello L; Hoyos M; Ramírez JJ; Hinojosa J; Molés JR; García A; Berenguer M; Berenguer J
    Rev Esp Enferm Dig; 1996 Jul; 88(7):470-4. PubMed ID: 8924324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating immune complexes in ulcerative colitis.--II. Correlation with serum protein concentrations and complement conversion products.
    Nielsen H; Petersen PH; Svehag SE
    Clin Exp Immunol; 1978 Jan; 31(1):81-91. PubMed ID: 639352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.